Aeon Biopharma Inc (AEON)

Aeon Biopharma Inc. has seen no insider trading activity within the last 90 days. The most recent transactions occurred in May 2025, when insider Jost Fischer executed three consecutive open market purchases totaling 170,000 shares. Prior to these acquisitions, an affiliate reported a proposed sale of shares in July 2024.
Ticker: AEON Exchange: ASE


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Aeon Biopharma Inc. Upgrade to see score, net flow, insiders and the full signal context.

Top insiders
Trades
Buy 21 May 2025
Value US$2,187,785.54 | Price 327.37 | Shares 72,978 (+30.0%)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value
Number of shares Price Value Details
2025-05-23 2025-05-21 B Purchase Non-Executive Director
72,978 +30.0%
327.37
US$2,187,786
72,978 +30.0% 327.37 US$2,187,786
2025-05-21 2025-05-20 B Purchase Non-Executive Director
31,590 +21.8%
271.18
US$3,982,220
31,590 +21.8% 271.18 US$3,982,220
2025-05-21 2025-05-19 B Purchase Non-Executive Director
79,027 +10.8%
216.32
US$756,450
79,027 +10.8% 216.32 US$756,450
2024-07-29 2024-07-29 PrS Proposed sale

Affiliate

201,825
2.63
US$530,780
201,825 2.63 US$530,780